EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expression of HER2, CD34, and EBV infection in gastric cancer, do they relate?

Alexandra Pinheiro, Diana Martins, Clara Rocha, Fernando Melo, Inês Morais, Inês Colaço, Sara Andrade, Rui Caetano, Patrícia Carreira, Fernando Mendes

Journal of Health Sciences · 2024

DOI: 10.17532/jhs.2023.2622 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Health Sciences, 2024. Verfasst von Alexandra Pinheiro und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Gastric cancer (GC), as a multifactorial disease, exhibits a complex pathogenesis, having intra and inter-tumor heterogeneity, challenging the efficacy of current treatments. GC is a major global health problem, and better diagnostic and therapeutic strategies are needed, leading to further biomarkers research associated with innovative targeted therapies. Our aim was to study human epidermal growth factor receptor 2 (HER2), Epstein Barr virus (EBV), and CD34 expression in GC samples to understand the relationship between these markers and relate them with the clinicopathological characteristics.

Methods

Thirty samples of primary carcinoma gastrectomy cases performed between February 2017 and December 2021 at the Hospital Distrital da Figueira da Foz, EPE, were studied after approval by the Ethics Committee. Immunohistochemistry assays were performed in sections of the selected tumor representative samples.

Results

All samples were negative for EBV and only two GC samples were positive for HER2. A significant statistical relationship was found between gender and CD34+ stroma cells. Microvascular density and stroma CD34+ cells presented relations with clinicopathological features and a positive tendency between them. Our study was able to identify a relationship between CD34+ stroma cells and females.

Conclusion

With this study, we mainly explored the potential role of CD34 as a biomarker in GC and projected possible associations of prognostic and therapeutic value toward other HER2 and EBV markers.

Zitieren

APA

Pinheiro, A., Martins, D., Rocha, C., Melo, F., Morais, I., Colaço, I., Andrade, S., Caetano, R., Carreira, P., & Mendes, F. (2024). Expression of HER2, CD34, and EBV infection in gastric cancer, do they relate?. Journal of Health Sciences. https://doi.org/10.17532/jhs.2023.2622

Vancouver

Pinheiro A, Martins D, Rocha C, Melo F, Morais I, Colaço I, et al. Expression of HER2, CD34, and EBV infection in gastric cancer, do they relate?. Journal of Health Sciences. 2024. doi:10.17532/jhs.2023.2622

BibTeX
@article{Pinheiro2024,
  author = {Pinheiro, Alexandra and Martins, Diana and Rocha, Clara and Melo, Fernando and Morais, Inês and Colaço, Inês and Andrade, Sara and Caetano, Rui and Carreira, Patrícia and Mendes, Fernando},
  title = {Expression of HER2, CD34, and EBV infection in gastric cancer, do they relate?},
  journal = {Journal of Health Sciences},
  year = {2024},
  doi = {10.17532/jhs.2023.2622}
}
Kostenlos starten →